_:n8f0fc1e8a44e404ebd5aec3d1f55b06cxb0
<http://schema.org/mainEntityOfPage>
<https://www.prnewswire.com/news-releases/a-drug-before-its-time-leukine-systematic-review-highlights-innate-and-adaptive-immune-activity-that-may-improve-cancer-outcomes-and-reduce-toxicity-301357229.html>